- Drug Pipelines
- January 2024
- 90 Pages
Global
From €1948EUR$2,000USD£1,665GBP
- Report
- July 2022
- 240 Pages
Global
From €1948EUR$2,000USD£1,665GBP
- Report
- November 2021
- 600 Pages
Global
From €3896EUR$4,000USD£3,331GBP
Rofecoxib is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. It is a member of the coxib class of drugs, which are selective inhibitors of the enzyme cyclooxygenase-2 (COX-2). Rofecoxib is used to treat mild to moderate pain, including menstrual cramps, osteoarthritis, and rheumatoid arthritis. It is also used to reduce fever and to treat acute pain. Rofecoxib is available in tablet form and is taken orally.
Rofecoxib is one of the most widely used analgesics in the world. It is used to treat a variety of conditions, including pain, inflammation, and fever. It is generally well tolerated and has few side effects. However, it has been linked to an increased risk of cardiovascular events, such as heart attack and stroke. As a result, it has been withdrawn from the market in many countries.
Some of the companies in the Rofecoxib market include Merck & Co., Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more